COSCIENS Biopharma Inc. (CSCIF)
OTCMKTS
· Delayed Price · Currency is USD
2.600
-0.040 (-1.52%)
At close: Sep 17, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
| Active Ingredient | 11.63M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopharmaceutical | 1.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopharmaceutical Growth | -75.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
| United States | 9.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany | 1.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom | 1.34M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Colombia | 410.99K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 356.19K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 449.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ireland | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ireland Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Denmark | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Denmark Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|